ACQUISITION OF DRUGS LEVODOPA 200 MG. + BENSERAZIDE 50 MG CM PROLOPA MELITASE SECOND CALL
About This Opportunity
TranslatedThis tender concerns the second call for the acquisition of pharmaceutical drugs, specifically Levodopa 200 mg combined with Benserazide 50 mg, under the brand name Prolopa Melitase. The procurement aims to secure a supply of this essential medication, which is commonly used in the treatment of Parkinson's disease and other related movement disorders. The specific formulation required is a combination product, indicating a need for a precise pharmaceutical composition. Interested suppliers are expected to provide high-quality, registered pharmaceutical products that meet all relevant regulatory standards for safety and efficacy. The tender likely involves detailed specifications regarding packaging, shelf life, and delivery timelines. Potential bidders should review the full tender documentation for precise quantities, delivery locations, and submission deadlines. This procurement is critical for ensuring the continuity of treatment for patients relying on this medication. Further details regarding the tendering process, eligibility criteria, and evaluation methodology will be available in the complete tender announcement. The contracting authority seeks reliable suppliers capable of fulfilling this important healthcare need.
This is a services contract in the health and medical services, information and communication technology and transport and logistics sectors. Located in Chile, Latin America, this opportunity is open to firms and consortiums.
Published through Chile Mercado Publico, a national government procurement portal. Public procurement tenders follow the country's national bidding regulations and may have specific eligibility and documentation requirements for services in the health and medical services sector. Service contracts are typically evaluated on both technical quality and price, and may require bidders to demonstrate relevant experience and qualified personnel. This contract has already been awarded. The information is published for transparency and market intelligence purposes.
Description
Original language: SpanishThis tender, issued by an undisclosed contracting authority in Chile, seeks the procurement of pharmaceutical products. Specifically, the requirement is for Levodopa 200 mg + Benserazide 50 mg, presented under the brand name Prolopa Melitase. This is identified as the "Segundo Llamado," indicating a second invitation to tender for this specific requirement.
The procurement pertains to essential medications, likely for public health services or a healthcare institution within Chile, given the source of the tender information. Suppliers are expected to provide a detailed offer for the supply of these pharmaceutical formulations. Typical requirements for such tenders include demonstrating compliance with national and international pharmaceutical quality standards, such as Good Manufacturing Practices (GMP), and presenting relevant product registration and authorization from Chilean health authorities. Bidders will likely need to submit comprehensive product specifications, evidence of manufacturing capacity, and robust supply chain management plans to ensure timely and reliable delivery. Furthermore, proposals will typically require detailed pricing structures, including unit costs and any applicable taxes or fees, alongside proposed delivery schedules and terms of payment. Experience in supplying similar pharmaceutical products to public sector entities may also be a consideration.
This procurement represents a significant opportunity for pharmaceutical manufacturers and distributors to engage with the Chilean healthcare market.
Data provenance
This notice is sourced from Chile Mercado Publico and was originally published on March 7, 2026. Last refreshed 27 days ago. Original language: Spanish. BidsFactory mirrors official procurement notices and links back to the source for full legal text.
Frequently asked questions about this tender
What type of contract is this?
This is a Services contract in the Health & Medical sector. The classification helps bidders match the opportunity to their qualifications and registered scope of supply.
How much was the contract awarded for?
CLINICAL MARKET S.A. was awarded the contract for CLP 55,900,000. The figure reflects the value disclosed by the contracting authority in the award notice.
Where will the contract be performed?
The contract is for delivery in Chile. Foreign bidders should review local registration, taxation, and any in-country presence requirements before submitting.
How can I submit a bid?
Visit Chile Mercado Publico to access the full notice, required documents, and submission instructions provided by the contracting authority.
Is this tender still open?
No — the contract has already been awarded to CLINICAL MARKET S.A.. The award notice is archived on BidsFactory for transparency and market intelligence.
Find tenders like this automatically
Set up alerts and filters that match your business — never miss a relevant opportunity again.